Garlic for cardiovascular disease: Prevention or treatment?

dc.contributor.authorAlali, Feras Qasem
dc.contributor.authorEl-Elimat, Tamam M.
dc.contributor.authorKhalid, Lila
dc.contributor.authorHudaib, Reema
dc.contributor.authorAl-Shehabi, Tuqa Saleh
dc.contributor.authorEid, Ali H.
dc.contributor.departmentPharmacology and Toxicology
dc.contributor.facultyFaculty of Medicine (FM)
dc.contributor.institutionAmerican University of Beirut
dc.date.accessioned2025-01-24T11:39:29Z
dc.date.available2025-01-24T11:39:29Z
dc.date.issued2017
dc.description.abstractCardiovascular disease (CVD) is the leading cause of global mortality with a substantial economic impact. The annual deaths are expected to increase in the next decade. An array of dietary supplements is being used by people worldwide to ameliorate cardiovascular risk factors. Garlic (Allium sativum L.), a top-selling herbal dietary supplement, is renowned for its wide range beneficial effects, particularly in the treatment and prevention of CVD. This review aims to present a thorough discussion of the available evidence-based data which support the use of garlic in the treatment or prevention of cardiovascular diseases, including atherosclerosis, hypertension, and hyperlipidemia. The molecular mechanisms underlying these effects are dissected as well. This review supports the notion that garlic has the potential to treat mild hypertension, to decrease hypercholesterolemia, and to prevent atherosclerosis. More clinical studies are essential to unequivocally understand the mechanisms underlying treatment or prevention of these cardiovascular conditions. © 2017 Bentham Science Publishers.
dc.identifier.doihttps://doi.org/10.2174/1381612822666161010124530
dc.identifier.eid2-s2.0-85020929215
dc.identifier.pmid27748188
dc.identifier.urihttp://hdl.handle.net/10938/29248
dc.language.isoen
dc.publisherBentham Science Publishers B.V.
dc.relation.ispartofCurrent Pharmaceutical Design
dc.sourceScopus
dc.subjectAllium sativum
dc.subjectAtherosclerosis
dc.subjectCardiovascular disease
dc.subjectGarlic
dc.subjectHerbal medicine
dc.subjectHyperlipidemia
dc.subjectHypertension
dc.subjectThrombosis
dc.subjectAnimals
dc.subjectCardiovascular diseases
dc.subjectDietary supplements
dc.subjectHumans
dc.subjectHypercholesterolemia
dc.subjectRisk factors
dc.subjectAbc transporter a1
dc.subjectAbc transporter g5
dc.subjectAbc transporter g8
dc.subjectArginine
dc.subjectCd36 antigen
dc.subjectCholesterol
dc.subjectEndothelial nitric oxide synthase
dc.subjectGarlic extract
dc.subjectHigh density lipoprotein cholesterol
dc.subjectHydrogen sulfide
dc.subjectLiver x receptor alpha
dc.subjectLow density lipoprotein cholesterol
dc.subjectNeuronal nitric oxide synthase
dc.subjectNitric oxide
dc.subjectNitric oxide synthase
dc.subjectTetrahydrobiopterin
dc.subjectTriacylglycerol
dc.subjectAnaphylaxis
dc.subjectBloating
dc.subjectChemical composition
dc.subjectClinical effectiveness
dc.subjectConcentration response
dc.subjectContact dermatitis
dc.subjectDiet supplementation
dc.subjectDietary intake
dc.subjectDrug activity
dc.subjectDrug formulation
dc.subjectDrug safety
dc.subjectEpigastric pain
dc.subjectEsophagus pain
dc.subjectEvidence based medicine
dc.subjectFlatulence
dc.subjectHematemesis
dc.subjectHuman
dc.subjectIntestine obstruction
dc.subjectNausea
dc.subjectNonhuman
dc.subjectPatient counseling
dc.subjectPemphigus
dc.subjectPharmacokinetic parameters
dc.subjectPhase 2 clinical trial (topic)
dc.subjectPhase 3 clinical trial (topic)
dc.subjectPhase 4 clinical trial (topic)
dc.subjectPhotoallergy
dc.subjectPriority journal
dc.subjectRectum hemorrhage
dc.subjectRegulatory mechanism
dc.subjectReview
dc.subjectThrombocyte aggregation
dc.subjectThrombocyte aggregation inhibition
dc.subjectTreatment duration
dc.subjectTreatment outcome
dc.subjectTreatment response
dc.subjectUrticaria
dc.subjectAnimal
dc.subjectChemistry
dc.subjectDietary supplement
dc.subjectRisk factor
dc.titleGarlic for cardiovascular disease: Prevention or treatment?
dc.typeReview

Files

Original bundle

Now showing 1 - 1 of 1
Loading...
Thumbnail Image
Name:
2017-8997.pdf
Size:
938.94 KB
Format:
Adobe Portable Document Format